Otsuka Pakistan Limited (PSX:OTSU)

Market Cap	3.46B +51.0%
Revenue (ttm)	4.15B +12.4%
Net Income	348.30M +1,013.9%
EPS	28.80 +1,012.7%
Shares Out	12.10M
PE Ratio	9.94
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	37,582
Open	281.02
Previous Close	n/a
Day's Range	281.00 - 287.57
52-Week Range	254.95 - 478.89
Beta	0.90
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About Otsuka Pakistan

Otsuka Pakistan Limited manufactures, markets, and distributes intravenous infusions in Pakistan and Afghanistan. The company offers intravenous solutions, including electrolyte and standard solutions, ampoules, OTSUZOL, and ciprofloxacin and OTSUMOL infusion products; medical devices, such as urea breath test systems, plasline solutions, clinical nutrition products comprising aminoleban oral, aminovel 600, pan-amin G, aminoleban injection, fatolip, and proten gold; and therapeutic drugs, which include pletaal and mucosta tablets, as well as or...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1988
• Employees: 408
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: OTSU